You just read:

Akcea Therapeutics Announces Launch of IN-FOCUS, a Research Study to Assess Impact of Familial Chylomicronemia Syndrome

News provided by

Ionis Pharmaceuticals, Inc.

Jun 29, 2016, 07:00 ET